Cargando…

MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer

BACKGROUND: It is known that the vast majority of prostate cancers are multifocal. However radical radiotherapy historically treats the whole gland rather than individual cancer foci. Magnetic resonance spectroscopy (MRS) can be used to non-invasively locate individual cancerous tumours in prostate....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kazi, Aleksandra, Godwin, Guy, Simpson, John, Sasso, Giuseppe
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Technical Advance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941503/ https://www.ncbi.nlm.nih.gov/pubmed/20809986 http://dx.doi.org/10.1186/1471-2407-10-472

Ejemplares similares

MRI‐TRUS registration methodology for TRUS‐guided HDR prostate brachytherapy
por: McGeachy, Philip, et al.
Publicado: (2021)

Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts
por: Goodman, Christopher D., et al.
Publicado: (2019)

Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer
por: Abe, Eisuke, et al.
Publicado: (2010)

Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy
por: Chapman, Christopher H, et al.
Publicado: (2018)

Simple phantom fabrication for MRI‐based HDR brachytherapy applicator commissioning
por: Fagerstrom, Jessica M., et al.
Publicado: (2020)

Dosimetric Uncertainties in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy
por: Zhou, Jun, et al.
Publicado: (2021)

Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study
por: Kim, Yeon Joo, et al.
Publicado: (2020)

Rectal dosimetry in intracavitary brachytherapy by HDR at rural center of Maharashtra: Comparison of two methods
por: Shrivastava, Rajeev, et al.
Publicado: (2009)

An innovative method to acquire the location of point A for cervical cancer treatment by HDR brachytherapy
por: Chang, Liyun, et al.
Publicado: (2016)

Prostate brachytherapy: HDR or seed implant
por: Das, K. R.
Publicado: (2006)

Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour
por: Gaudreault, Mathieu, et al.
Publicado: (2022)

Volumetric and Voxel-Wise Analysis of Dominant Intraprostatic Lesions on Multiparametric MRI
por: Lee, Joon, et al.
Publicado: (2019)

The use of nomograms in LDR-HDR prostate brachytherapy
por: Pujades, Ma Carmen, et al.
Publicado: (2011)

Cosmetic effect in patients with early breast cancer treated with breast conserving therapy (BCT) and with HDR brachytherapy (HDR-BT) “boost”
por: Kulik, Anna, et al.
Publicado: (2009)

Vital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer
por: Chicheł, Adam, et al.
Publicado: (2009)

Ada-WHIPS: explaining AdaBoost classification with applications in the health sciences
por: Hatwell, Julian, et al.
Publicado: (2020)

Waist circumference prediction for epidemiological research using gradient boosted trees
por: Zhou, Weihong, et al.
Publicado: (2021)

External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost
por: Panettieri, Vanessa, et al.
Publicado: (2020)

Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI
por: Harvey, Hugh, et al.
Publicado: (2017)

HDR Brachytherapy in the Management of High-Risk Prostate Cancer
por: Masson, Susan, et al.
Publicado: (2012)

Improved assessment of multiple sclerosis lesion segmentation agreement via detection and outline error estimates
por: Wack, David S, et al.
Publicado: (2012)

Prostate Stereotactic Ablative Radiation Therapy Using Volumetric Modulated Arc Therapy to Dominant Intraprostatic Lesions()
por: Murray, Louise J., et al.
Publicado: (2014)

Feasibility and safety of definite volumetric modulated arc therapy with simultaneous integrated boost to the dominant intraprostatic lesion in patients with unfavorable intermediate to high-risk prostate cancer
por: Dankulchai, Pittaya, et al.
Publicado: (2022)

Percutaneous acetabuloplasty for metastatic acetabular lesions
por: Maccauro, Giulio, et al.
Publicado: (2008)

Spheroids as a model for endometriotic lesions
por: Song, Yong, et al.
Publicado: (2023)

Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”
por: Masson, Susan, et al.
Publicado: (2016)

MR-guided HDR prostate brachytherapy with teleoperated steerable needles
por: de Vries, M., et al.
Publicado: (2023)

Combining next‐generation sequencing and progeny testing for rapid identification of induced recessive and dominant mutations in maize M(2) individuals
por: Heuermann, Marc C., et al.
Publicado: (2019)

Radiotherapy planning in a prostate cancer phantom model with intraprostatic dominant lesions using stereotactic body radiotherapy with volumetric modulated arcs and a simultaneous integrated boost
por: Skrobala, Agnieszka, et al.
Publicado: (2023)

HDR brachytherapy (HDR–BT) combined with stent placement in palliative treatment of esophageal cancer
por: Kanikowski, Marek, et al.
Publicado: (2009)

Dose correction in lung for HDR breast brachytherapy
por: Slessinger, Eric, et al.
Publicado: (2012)

Mutational profiling of micro-dissected pre-malignant lesions from archived specimens
por: Nachmanson, Daniela, et al.
Publicado: (2020)

A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2019)

Szabo 2-stent technique for coronary bifurcation lesions: procedural and short-term outcomes
por: Yang, Hongbo, et al.
Publicado: (2020)

Lesion probability mapping in MS patients using a regression network on MR fingerprinting
por: Hermann, Ingo, et al.
Publicado: (2021)

HDR brachytherapy as a solution in recurrences of locally advanced prostate cancer
por: Łyczek, Jarosław, et al.
Publicado: (2009)

3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer – an interobserver variability study
por: Rischke, Hans Christian, et al.
Publicado: (2013)

Quantification of the margin required for treating intraprostatic lesions
por: Studenski, Matthew T., et al.
Publicado: (2016)

Robotic assisted-bronchoscopy: technical tips and lessons learned from the initial experience with sampling peripheral lung lesions
por: Murgu, Septimiu Dan
Publicado: (2019)

Dosimetric comparison of surface mould HDR brachytherapy with VMAT
por: Boman, Eeva L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gv203fkd14260g5u4m4vnmi8an